News Archive

2018

September

Media Release / Sep 24, 2018

Novartis announces five grant recipients of eXcellence in Ophthalmology Vision Award (XOVA) for nonprofit sustainable eye health initiatives

Read More
Media Release / Sep 22, 2018

Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness

Read More
Media Release / Sep 22, 2018

New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD

Read More
Media Release / Sep 21, 2018

Sandoz receives positive CHMP opinion for proposed biosimilar pegfilgrastim

Read More
Media Release / Sep 21, 2018

Novartis receives positive CHMP opinion for Gilenya® for the treatment of children and adolescents with MS, marking a major medical advance for young MS patients in Europe

Read More
Media Release / Sep 21, 2018

Novartis announces positive CHMP opinion for one-time gene therapy Luxturna® to treat children and adults with rare inherited retinal disease

Read More
Media Release / Sep 17, 2018

World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime

Read More
Media Release / Sep 17, 2018

Launch of Alcon Experience Academy Reinforces Commitment to Training and Education for Eye Care Professionals

Read More
AMD_Awareness_Week_Deirde O'Kane
Story / Sep 14, 2018

Deirdre O’Kane Launches AMD Awareness Week

Read More
Media Release / Sep 13, 2018

Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx® in daily life for psoriasis patients

Read More

Pages

Related Links